Why the study?
The prevalence of acetylsalicylic acid resistance is unknown, and the study aimed to evaluate its temporal variability and relationship with mean platelet volume in ACS patients.
The prevalence of acetylsalicylic acid resistance increases significantly within the first month following acute coronary syndrome and percutaneous coronary intervention.
Supports hypothesis of MPV-linked ASA resistance variability in ACS; leaves open need for prospective validation before practice change.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Uçar et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: